title: Sandostatin therapy of acute oesophageal variceal bleeding.
abstract: This communication deals with the emergency control of variceal bleeding rather than the prevention of rebleeding. The current main options of oesophageal tamponade, emergency sclerotherapy and drug therapy are discussed, with particular reference to the use of somatostatin. Sandostatin (Sandoz, Basel), a synthetic long-acting somatostatin analogue, was found to reduce transhepatic venous gradient by 30% with no effect on systemic haemodynamics in a study of 16 stable cirrhotic patients. In a trial comparing intravenous infusion of Sandostatin (SMS) to oesophageal tamponade (OT) in active variceal bleeding, 18 of 20 bleeds in the SMS group and 19 of 20 bleeds in the OT group were controlled at 4 h. Ten in the SMS group and 14 in the OT group had no further bleeding during the 48-hour study period. Thus SMS may be useful in the temporary control of active variceal bleeding.
authors.affiliation: Aberdeen Royal Infirmary, Foresterhill, UK.
authors.forename: R F
authors.initials: RF
authors.lastname: McKee
mesh_terms: D000208:Acute Disease; D021721:Balloon Occlusion; D002404:Catheterization; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*; D015911:Sclerotherapy; D013997:Time Factors
chemical_list: D015282:Octreotide